• Perspective Therapeutics' (CATX) Outperform Rating Reiterated at Wedbush

    Source: Buzz FX / 18 Mar 2025 17:31:16   America/Chicago


    Perspective Therapeutics' (CATX) Outperform Rating Reiterated at Wedbush Written by MarketBeat March 18, 2025 Share Link copied to clipboard. Remove Ads Perspective Therapeutics ( NYSE:CATX - Get Free Report ) 's stock had its "outperform"
    Read more...
Share on,